Synapse - Elgilda Musi

Elgilda Musi

Research Focus

Former Employee. SKI Medicine; Research Asst, Sr

Recent additions – View all

BIBF1120, an investigational triple angiokinase inhibitor, in combination with inhibitors of mTOR signaling shows potent antitumor activity in preclinical models of sarcoma
Meeting Abstract

Patwardhan, P. P.; Musi, E.; Ivy, K. S.; Giovino, N.; Schwartz, G. K.
Cancer Research (2014)

Fulltext@MSK | Save
The phosphoinositide 3-kinase a selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells
Journal Article

Musi, E.; Ambrosini, G.; de Stanchina, E.; Schwartz, G. K.
Molecular Cancer Therapeutics (2014)

Fulltext@MSK | Save
The parp inhibitor olaparib (AZD2281) greatly enances the effect of temozolomide in soft tissue sarcoma cell lines
Meeting Abstract

Musi, E.; Ambrosini, G.; Schwartz, G. K.
Cancer Research (2013)

Fulltext@MSK | Save

Co-authors at MSK

8

Schwartz
6

Ambrosini
4

De Stan...
2

Ho
1

Carvajal
1

Coward
1

D'Adamo
1

Deraje ...
1

Dickson
1

Giovino
1

Haimovi...
1

Ivy
1

Keohan
1

Luke
1

Maki
1

Nair
1

Patwardhan
1

Singer
1

Truman

Types of Work

Publications